Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 223 entries
View as:

A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

Phase: N/A Priority: Normal
NCT ID: NCT00872196 Org: User:
Start: 04/30/09 End: 04/30/10 Due: 04/30/11

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01137526 Org: User:
Start: 05/31/10 End: 07/31/11 Due: 07/31/12

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Phase: N/A Priority: Normal
NCT ID: NCT01662336 Org: User:
Start: 06/30/12 End: 06/30/16 Due: 06/30/17

Study of Adalimumab in Patients With Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00939003 Org: User:
Start: 07/31/09 End: 08/31/13 Due: 08/31/14

A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01085422 Org: User:
Start: 04/30/10 End: 06/30/11 Due: 06/30/12

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

Phase: N/A Priority: Normal
NCT ID: NCT01759264 Org: User:
Start: 01/31/13 End: 05/31/14 Due: 05/31/15

Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00691964 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01756235 Org: User:
Start: 12/31/12 End: 10/31/15 Due: 10/31/16

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Phase: N/A Priority: Normal
NCT ID: NCT01073462 Org: User:
Start: 12/31/08 End: 06/30/13 Due: 06/30/14

Kaletra: Therapy With Double Protease Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01075191 Org: User:
Start: 01/31/04 End: 09/30/11 Due: 09/30/12

A Study on the Prevalence of the Modified Citrullinated Vimentin Anti-body (Anti-MCV) in an Irish Rheumatoid Arthritis (RA) Population and to Assess the Impact of Anti-MCV and the Anti-cyclic-citrullinated Peptide Antibody (Anti-CCP) Status on the Management of Irish Patients With Early RA

Phase: N/A Priority: Normal
NCT ID: NCT01078597 Org: User:
Start: 09/30/10 End: 07/31/13 Due: 07/31/14

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00868413 Org: User:
Start: 11/30/09 End: 05/31/13 Due: 05/31/14

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01265992 Org: User:
Start: 02/28/11 End: 11/30/12 Due: 11/30/13

Acute Pain Study Following Bunionectomy

Phase: N/A Priority: Normal
NCT ID: NCT01333722 Org: User:
Start: 04/30/11 End: 06/30/11 Due: 06/30/12

A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494

Phase: N/A Priority: Normal
NCT ID: NCT01741493 Org: User:
Start: 11/30/12 End: 12/31/13 Due: 12/31/14

Study of ABT-700 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01472016 Org: User:
Start: 10/06/11 End: 04/27/17 Due: 04/27/18

A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00443391 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01163318 Org: User:
Start: 12/31/09 End: 05/31/14 Due: 05/31/15

A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00853099 Org: User:
Start: 02/28/09 End: 08/31/13 Due: 08/31/14

A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01243671 Org: User:
Start: 10/31/10 End: 06/30/13 Due: 06/30/14

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01646073 Org: User:
Start: 08/31/12 End: 12/31/13 Due: 12/31/14

Quality of Life and Psychosocial Factors Associated With Severe Psoriasis Following Treatment With Adalimumab

Phase: N/A Priority: Normal
NCT ID: NCT01328366 Org: User:
Start: 05/31/11 End: 05/31/14 Due: 05/31/15

Surveillance of Kaletra in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT01083173 Org: User:
Start: 10/31/09 End: 10/31/14 Due: 10/31/15

An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01406119 Org: User:
Start: 10/31/11 End: 01/31/17 Due: 01/31/18

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT00851890 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10